Barretina et al. [12] reported 3.128-, 3.689-, 3.766- and 2.159-fold increased expression of SMC1A in pleomorphic liposarcoma, leiomyosarcoma, myxosarcoma and dedifferentiated liposarcoma, respectively (Table 1). This evidence concerns the gene SMC1A and leiomyosarcoma.